Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Akshay Kharat"'
Autor:
Sundar Jagannath, Nedra Joseph, Concetta Crivera, Akshay Kharat, Carolyn C. Jackson, Satish Valluri, Patricia Cost, Hilary Phelps, Rafal Slowik, Timothy Klein, Lee Smolen, Xueting Yu, Adam D. Cohen
Publikováno v:
Oncology and Therapy, Vol 11, Iss 2, Pp 263-275 (2023)
Abstract Introduction Ciltacabtagene autoleucel (cilta-cel), is a B-cell maturation antigen-directed, genetically modified autologous chimeric antigen receptor T-cell (CAR-T) immunotherapy. It is indicated for treatment for adult patients with relaps
Externí odkaz:
https://doaj.org/article/ac25c55cc6c14ce2a868c9a66e746631
Autor:
Mark Alberts, Maryia Zhdanava, Dominic Pilon, Gabrielle Caron-Lapointe, Patrick Lefebvre, Brahim Bookhart, Akshay Kharat
Publikováno v:
Advances in Therapy. 40:2339-2354
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b407d19cfb50995559ba010971a1895f
https://doi.org/10.1007/s12325-023-02483-4
https://doi.org/10.1007/s12325-023-02483-4
Autor:
Mark Alberts, Maryia Zhdanava, Dominic Pilon, Gabrielle Caron-Lapointe, Patrick Lefebvre, Brahim Bookhart, Akshay Kharat
Publikováno v:
Advances in Therapy. 40:1750-1764
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e693e12566a3f13914cc03ce3d263ab
https://doi.org/10.1007/s12325-022-02391-z
https://doi.org/10.1007/s12325-022-02391-z
Publikováno v:
Blood Coagulation & Fibrinolysis. 33:301-309
This study was conducted in patients treated for initial venous thromboembolism (VTE) for approximately 6 months to enhance understanding of the risk factors to inform clinical decision-making about long-term anticoagulation therapy. This retrospecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff7dde70fe9763cb946f6be05973ed88
https://doi.org/10.1097/mbc.0000000000001140
https://doi.org/10.1097/mbc.0000000000001140
Autor:
François Laliberté, Connie N. Hess, Marc P. Bonaca, John Benson, Peter Zuckerman, Dejan Milentijevic, Urvi Desai, Akshay Kharat, William R. Hiatt, Patrick Lefebvre
Publikováno v:
Annals of Vascular Surgery. 75:217-226
Background Patients with peripheral artery disease (PAD) treated with lower extremity revascularization are at increased risk of major atherothrombotic vascular events (acute limb ischemia (ALI), major non-traumatic lower-limb amputation, myocardial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43979c27e3a17fe563f3ef9a6908b4e9
https://doi.org/10.1016/j.avsg.2021.02.025
https://doi.org/10.1016/j.avsg.2021.02.025
Autor:
Patrick Lefebvre, John Benson, Marc P. Bonaca, Connie N. Hess, William R. Hiatt, Urvi Desai, Peter Zuckerman, Akshay Kharat, Dejan Milentijevic, François Laliberté
Publikováno v:
Journal of Medical Economics. 24:402-409
Peripheral artery disease (PAD), often treated with lower extremity revascularization, is associated with risk of major atherothrombotic vascular events (acute limb ischemia [ALI], major non-traumatic lower-limb amputation, myocardial infarction [MI]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::956a16e388d9624c9b4001b91041e38a
https://doi.org/10.1080/13696998.2021.1891089
https://doi.org/10.1080/13696998.2021.1891089
Publikováno v:
International Journal of Orthopaedics Sciences. 6:900-903
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d7140b962806dc9fa2c6c7f3064777e
https://doi.org/10.22271/ortho.2020.v6.i2o.2157
https://doi.org/10.22271/ortho.2020.v6.i2o.2157
Publikováno v:
American journal of cardiovascular drugs : drugs, devices, and other interventions. 22(4)
Current evidence suggests that rivaroxaban may be well tolerated and effective in patients with nonvalvular atrial fibrillation (NVAF) and obesity; however, there is limited evidence on the impact of polypharmacy in this population. This study evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caf423e22d8ccb0f38737aeba1f18d19
https://pubmed.ncbi.nlm.nih.gov/35092000
https://pubmed.ncbi.nlm.nih.gov/35092000
Publikováno v:
Current medical research and opinion. 38(1)
OBJECTIVE To perform a systematic literature review and indirect treatment comparison (ITC) to identify, summarize and quantify randomized controlled trial (RCT) evidence evaluating combination anticoagulant or P2Y12 inhibitor with low-dose aspirin v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc6b11f76252c9b7b9e8d3247b60aa7c
https://pubmed.ncbi.nlm.nih.gov/34641745
https://pubmed.ncbi.nlm.nih.gov/34641745
Autor:
François Laliberté, Veronica Ashton, Dominique Lejeune, Kenneth Todd Moore, Akshay Kharat, Young Jung, Jeffrey S. Berger, Patrick Lefebvre
Publikováno v:
Journal of comparative effectiveness research. 10(16)
Aim: Evaluate healthcare resource utilization (HRU) and costs associated with rivaroxaban and warfarin among nonvalvular atrial fibrillation (NVAF) patients with obesity and polypharmacy. Materials & methods: IQVIA PharMetrics ® Plus (January 2010
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a48558b422c0804a1ee90d5be22ed866
https://pubmed.ncbi.nlm.nih.gov/34378989
https://pubmed.ncbi.nlm.nih.gov/34378989